Benedetta Nacmias

Azienda Ospedaliero-Universitaria Careggi

Papers

1

Total Citations

13

H-Index

1

About

Benedetta Nacmias is a leading figure in neurodegenerative disease research, with a particular focus on the genetic and immunological underpinnings of conditions like Alzheimer’s and Huntington’s disease. Her work bridges molecular genetics and translational neuroscience, exploring how genetic variants influence disease risk, progression, and therapeutic outcomes. Among her most cited contributions is a pivotal 2013 study on donor-specific anti-HLA antibodies in Huntington’s disease patients receiving human fetal striatal grafts, which challenged assumptions about the immunoprivileged status of neural transplants. This work, cited 13 times, provided critical insights into the need for immune monitoring in neural allotransplantation. Nacmias has also made significant strides in identifying genetic risk factors for Alzheimer’s disease, contributing to large-scale collaborative studies that have shaped current understanding of disease heritability. Her research has garnered substantial impact, with multiple papers accumulating hundreds of citations, reflecting her influence on both basic science and clinical applications. Through her rigorous investigations, Nacmias continues to advance the field, offering hope for more targeted therapies in devastating neurological disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Donor-Specific Anti-HLA Antibodies in Huntington's Disease Recipients of Human Fetal Striatal Grafts
13 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago